Literature DB >> 17192773

Anticholinergic drugs and physical function among frail elderly population.

F Landi1, A Russo, R Liperoti, M Cesari, C Barillaro, M Pahor, R Bernabei, G Onder.   

Abstract

Increasing evidence from experimental studies and human observations suggests that drugs with anticholinergic properties can cause physical and mental impairment. The aim of this study was to evaluate the relationship between the use of drugs with anticholinergic activity and measures of physical performance, muscle strength, and functional status in persons aged 80 years or older. Data are from baseline evaluation of 364 subjects enrolled in the ilSIRENTE study. The ilSIRENTE study is a prospective cohort study performed in the mountain community living in the Sirente geographic area (L'Aquila, Abruzzo) in Central Italy. Physical performance was assessed using the physical performance battery score (Short Physical Performance Battery), which is based on three timed tests: 4-meter walking speed, balance, and chair stand tests. Muscle strength was measured by hand grip strength. We defined as anticholinergic drugs all medications for which serum anticholinergic activity was previously demonstrated. Analyses of covariance were performed to evaluate the relationship of anticholinergic drugs with physical function. In the unadjusted model, all the physical performance, muscle strength, and functional measures showed significant associations with the anticholinergic drug use. After adjustment for potential confounders (age, gender, smoking, physical activity level, cognitive performance score, living alone, body mass index, congestive heart failure, lung diseases, diabetes), these associations were weaker but still statistically significant (physical performance battery score: non-users anticholinergic drugs 6.9, SE 0.1, users anticholinergic drugs 6.1, SE 0.2, P=0.05; hand grip strength: non-users anticholinergic drugs 31.3 kg, SE 0.8, users anticholinergic drugs 28.8 kg, SE 1.0, P=0.05; Activities of Daily Living scale score: non-users anticholinergic drugs 1.2, SE 0.1, users anticholinergic drugs 1.6, SE 0.1, P=0.03; Instrumental Activities of Daily Living scale score: non-users anticholinergic drugs 2.7, SE 0.1, users anticholinergic drugs 3.4, SE 0.1, P<0.001). The use of medication with anticholinergic properties is common among community older subjects in Italy. Our results suggest that among old-old subjects the use of anticholinergic drugs is associated with impaired physical performance and functional status.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17192773     DOI: 10.1038/sj.clpt.6100035

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  51 in total

1.  Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients: A prospective study.

Authors:  Juho Uusvaara; Kaisu H Pitkala; Hannu Kautiainen; Reijo S Tilvis; Timo E Strandberg
Journal:  Drugs Aging       Date:  2011-02-01       Impact factor: 3.923

2.  A preliminary study of anticholinergic burden and relationship to a quality of life indicator, engagement in activities, in nursing home residents with dementia.

Authors:  Ann Kolanowski; Donna M Fick; Judy Campbell; Mark Litaker; Malaz Boustani
Journal:  J Am Med Dir Assoc       Date:  2009-01-09       Impact factor: 4.669

Review 3.  Classifying antipsychotic agents : need for new terminology.

Authors:  Ripu D Jindal; Matcheri S Keshavan
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

4.  Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis.

Authors:  Prasad S Nishtala; Sarah N Hilmer; Andrew J McLachlan; Paul J Hannan; Timothy F Chen
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

5.  Evidence-based guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary from AURO.it.

Authors:  Sebastiano Spatafora; Antonio Casarico; Andrea Fandella; Caterina Galetti; Rodolfo Hurle; Elisa Mazzini; Ciro Niro; Massimo Perachino; Roberto Sanseverino; Giovanni Luigi Pappagallo
Journal:  Ther Adv Urol       Date:  2012-12

Review 6.  Medication safety in residential aged-care facilities: a perspective.

Authors:  Nicholas M Wilson; Lyn M March; Philip N Sambrook; Sarah N Hilmer
Journal:  Ther Adv Drug Saf       Date:  2010-10

Review 7.  Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review.

Authors:  Mohammed Saji Salahudeen; Stephen B Duffull; Prasad S Nishtala
Journal:  Drugs Aging       Date:  2014-03       Impact factor: 3.923

8.  Potentially inappropriate medication use is associated with clinical outcomes in critically ill elderly patients with neurological injury.

Authors:  Catherine K Floroff; Patricia W Slattum; Spencer E Harpe; Perry Taylor; Gretchen M Brophy
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

9.  Racial disparities in the quality of medication use in older adults: baseline findings from a longitudinal study.

Authors:  Mary T Roth; Denise A Esserman; Jena L Ivey; Morris Weinberger
Journal:  J Gen Intern Med       Date:  2009-12-11       Impact factor: 5.128

10.  Drug burden index score and functional decline in older people.

Authors:  Sarah N Hilmer; Donald E Mager; Eleanor M Simonsick; Shari M Ling; B Gwen Windham; Tamara B Harris; Ronald I Shorr; Douglas C Bauer; Darrell R Abernethy
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.